Navigation Links
CeNeRx BioPharma Appoints Mahnaz Asgharnejad as Vice President of Clinical Development
Date:6/11/2008

-Former GSK Clinical Development Head Brings Over 20 Years of Clinical and

Product Development Expertise to the Company's CNS Portfolio-

RESEARCH TRIANGLE PARK, N.C., June 11 /PRNewswire/ -- CeNeRx BioPharma, Inc., a biopharmaceutical company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced the appointment of Dr. Mahnaz Asgharnejad as Vice President of Clinical Development. Dr. Asgharnejad will play a central role in expanding CeNeRx's clinical development capabilities and advancing the clinical trials of CeNeRx's investigational drugs. Previously, Dr. Asgharnejad spent more than two decades at GlaxoSmithKline (GSK), where she held clinical development positions of increasing responsibility, most recently as GSK's Senior Director of Psychiatry Clinical Development and Product Strategy.

"Dr. Asgharnejad is a leading CNS clinical development practitioner and we are delighted that she has chosen to join the CeNeRx team," said Daniel Burch, M.D., Executive Vice President of R&D and Chief Medical Officer of CeNeRx. "We expect her proven ability to lead successful clinical development programs addressing a variety of CNS disorders and her deep knowledge of the evolving clinical and regulatory landscape will contribute greatly to our progress going forward."

Dr. Asgharnejad's extensive industry experience includes more than 20 years of clinical program design and management. In recent years, she was responsible for developing and implementing development strategies for candidates at various clinical stages for disorders including unipolar and bipolar depression, ADHD, obesity and migraine. Dr. Asgharnejad has managed projects at all phases of development, including successful new product submissions to the FDA.

"CeNeRx's pipeline of novel candidates for CNS-related disorders with high unmet need presents an exceptional opportunity to leverage my varied expertise i
'/>"/>

SOURCE CeNeRx BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. ARCA Discovery Changes Name to ARCA biopharma to Reflect Focus on Drug Commercialization
2. XTL Biopharmaceuticals Announces Financial Results for the Year Ended December 31, 2007
3. Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
5. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
6. Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
7. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
8. PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets
9. amfAR Appoints Dr. Annette Sohn as Vice President of Global Initiatives
10. Disc Motion Technologies Appoints Industry Veteran as New CEO
11. Setaram Inc. Appoints New CEO/VP

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , WASHINGTON, Dec. 1 /PRNewswire-USNewswi...s medicine clinic in Los Angeles, has agreed to pa...ns that it received illegal kickbacks from HealthS... today. ,, The settlement resolves allegat...e in the form of stock option grants, donations to...
(Date:12/1/2009)...Even with equal care, very preterm births more lik...c. 1 (HealthDay News) -- Pregnant women who are po...than more affluent women, even though both groups ...shows. , The University of Leicester research t...e about the association between economic status an...
(Date:12/1/2009)... CAEAR Foundation Changes...ington, DC (Vocus) -- The CAEAR Foundation, one of..., is changing its name to HealthHIV and launching ...coincides with the start of a campaign to promote ...apabilities and reach. , , , , ,“HealthHIV ...
(Date:12/1/2009)..., , MEXICO CITY, Dec. 1 T...ll build a world-class center for biomedical and n... The center for medical research and development w...versity of Mexico, the top Spanish speaking univer...d to begin construction in 2010, has been designed...
(Date:12/1/2009)..., , SOUTHFIELD, Mich., Dec. 1 /PRNewswire-... (NYSE: FMR ) ("First Mercury" or the "Company"...ard of Directors declared a quarterly cash dividen...9 to shareholders of record at the close of busine...ury Financial Corporation ,, First Mercury Fin...
Breaking Medicine News(10 mins):Health News:Los Angeles' Kerlan Jobe Orthopaedic Clinic Pays $3 Million to Settle Kickback Allegations 2Health News:More Preemies Born Among the Poor 2Health News:National HIV Non-Profit Announces New Name 2Health News:Mexico City to Build World-Class Hub for Medical Research 2
...Stereotaxis to Demonstrate Advanced Coronary & Per...Road Mapping at TCT 2007 Stereotaxis, Mob...ct. 19 Stereotaxis, Inc. (Nasdaq:,STXS) announced...cular Therapeutics (TCT) symposium in Washington,D...
...BATON ROUGE, La., Oct. 19 Amedisys, Inc.,(Nasdaq:...home health,nursing companies, today announced tha...the quarter ended September 30, 2007 pre-market on...in the conference call, please dial 800-683-1525,(...
...WASHINGTON, Oct. 18 The following statement,is at...: "The American Medical Association (AMA) welcome...ral Andrew Cuomo to issue a consumer warning,about...become more,informed purchasers of health care. Ac...
...Sing to Live Community Chorus: ,It Takes A Village...e-Live to Sing, a,not-for-profit organization foun...ished to create an all-voice community chorus to p...ival,provides its singers a venue to share their l...
...LIONVILLE, Pa., Oct. 18 West Pharmaceutical,Servi...lated to Pfizer,Inc.,s announcement that it has de...le Insulin product, returning the marketing rights...Nektar. "We were surprised and disappointed by Pf...
...DALLAS, Oct. 18 The National Association of,Denta...ation to collaborate,on reauthorization of the Chi...lly, NADP urges prompt action to enact the dental ...g key points:, -- Dental services should be a m...
Other Medicine News:Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 2Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 3Health News:Stereotaxis Showcases Interventional Cardiology Capabilities of Niobe Magnetic Navigation System 4Health News:Amedisys to Host Conference Call to Discuss Third Quarter Financial Performance and Operating Results 2Health News:Breast Cancer Survivors and Their Supporters 'Sing to Live' 2Health News:West Pharmaceutical Services Issues Statement on Exubera 2Health News:West Pharmaceutical Services Issues Statement on Exubera 3Health News:West Pharmaceutical Services Issues Statement on Exubera 4Health News:NADP Calls on Congress and the White House to Work Together to Cover Children's Dental Health 2
(Date:12/1/2009)... , , LANSING, Mich., Dec. 1 /PRNewswire-Fi...nounced today that it has acquired the BioKits foo...robe Incorporated ( GPRO). The acquisition include...and fish speciation, and plant genetics. ,, Gen...cquisition of Tepnel Life Sciences plc in April 20...
(Date:12/1/2009)... , , BOTHELL, Wash., Dec. 1 /PRNewswir...D ) announced that on November 20, 2009 it license... Canada to manufacture and sell four extended rele...CDT® drug delivery platform. In addition, SC...two of such products in the United States on a non...
(Date:12/1/2009)... , , ATLANTA, Dec. 1 /PRNewswire-FirstCa...logical medical device and cardiovascular tissue p... guidance for 2010. ,, The Company expects tota... $118.0 million and $123.0 million, which includes...funding received from the Department of Defense in...
Breaking Medicine Technology:Neogen Acquires Gen-Probe's BioKits Food Safety Business 2SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Johns Hopkins Medical Institutions Deploys Perceptrak 28R 29 by Cernium 51620 1Johns Hopkins Medical Institutions Deploys Perceptrak 28R 29 by Cernium 51620 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 1Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 2Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 3Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 4Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 5Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 6Studies Presented at International Conference on Alzheimers Disease Reveal Substantial Economic Costs and Caregiver Burden Associated with Alzheimers 13021 7Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 1Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 2
...07 /PRNewswire/ -- A new study suggests,strong var...e,northern and southern U.S. Anaphylaxis is a seve...atment with epinephrine. The,striking north-south ...phylaxis risk, currently are without explanation. ...evels of vitamin D,from lack of sunshine, may play...
...is, often conducted in a physicians office practic...array of ailments; UTIs, diabetes, several cancers...iseases. The estimated global market for urinalys...r and is growing strongly. For such a fundamental,...rocedure, the manufacturers of urinalysis analyzer...
Other Medicine Technology:Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2Urinalysis Analyzers: Large Capabilities in Every Size Device 2Urinalysis Analyzers: Large Capabilities in Every Size Device 3
Access Vitamin B12
...ANTA LiteTM ANA is an enzyme-linked immunosorbent ...of anti-nuclear antibodies (ANA) in human serum. T... clinical findings and other laboratory tests to a...systemic lupus erythematosus, Sjgren's syndrome, s...
...muno Concepts manufactures slides that are compati...technologist to decrease the number of pipetting s...ple dilutions on the slides. Ask Immuno Concepts f... slides. These slide formats are noted with an * a...
...e ANA and ENA assays can be used to screen out pat...re associated with various systemic rheumatic dise... Sjgren's syndrome, mixed connective tissue diseas...lymyositis, dermatomyositis, and Raynaud's phenome...
Medicine Products: